Latest News

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...

B.P. Marsh & Partners PLC ( LON:BPM ) will increase its dividend on the 27th of February to £0.0698, which is 2.9...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

While Napatech A/S ( OB:NAPA ) shareholders have had a good week with the stock up 11%, they shouldn't let their guards...

Centrum Medyczne ENEL-MED S.A. ( WSE:ENE ) shareholders have had their patience rewarded with a 28% share price jump in...

There wouldn't be many who think DocMorris AG's ( VTX:DOCM ) price-to-sales (or "P/S") ratio of 0.3x is worth a mention...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Over the past year, many ADvTECH Limited ( JSE:ADH ) insiders sold a significant stake in the company which may have...

With a price-to-earnings (or "P/E") ratio of 6.2x Stalexport Autostrady S.A. ( WSE:STX ) may be sending very bullish...

SA Catana Group ( EPA:ALCAT ) has announced that on 5th of March, it will be paying a dividend of€0.13, which a...

Key Insights Significant control over Interparfums by public companies implies that the general public has more power...

KWS SAAT SE KGaA's (ETR:KWS) stock is up by a considerable 9.8% over the past month. Since the market usually pay for a...

Gobarto S.A. ( WSE:GOB ) shareholders would be excited to see that the share price has had a great month, posting a 32...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Columbia Banking System (COLB) has wrapped up FY 2025 with fourth quarter revenue of US$694 million and basic EPS of US$0.73, alongside trailing twelve month revenue of about US$2.2 billion and EPS of US$2.31. These results put fresh numbers on the table for investors watching its profitability story. Over recent periods, the company has seen revenue move from US$458.9 million in Q4 2024 to US$694 million in Q4 2025, while EPS shifted from US$0.69 to US$0.73. This sets the backdrop for how...

Earlier this week, law firm Johnson Fistel, PLLP announced it is investigating whether Merchants Bancorp or its executives violated federal securities laws by misrepresenting or withholding material information from investors, with a focus on potential loss recovery. The probe highlights growing legal and governance scrutiny around Merchants Bancorp’s disclosures, potentially influencing how investors assess the bank’s transparency and risk profile. We’ll now examine how this securities...

GSK has signed a definitive agreement to acquire RAPT Therapeutics (NasdaqGM:RAPT). The deal centers on ozureprubart, a long acting anti-IgE antibody in Phase IIb trials for food allergy prophylaxis. The transaction brings a food allergy candidate into GSK’s immunology and inflammation portfolio. RAPT Therapeutics, trading at $57.63, has recently seen very large 1 year returns and strong short term moves, with the share price up 64.2% over the past week and 60.8% over the past month. Year...

Northern Trust FY 2025 Earnings Snapshot Northern Trust (NTRS) just wrapped up FY 2025 with fourth quarter total revenue of US$2,131.1 million and basic EPS of US$2.41, alongside net income excluding extra items of US$452.3 million. The company has seen quarterly revenue move from US$1,970.1 million in Q4 2024 to US$2,131.1 million in Q4 2025. Over that same period, basic EPS shifted from US$2.27 to US$2.41 on a quarterly basis and from US$9.80 to US$8.78 on a trailing twelve month basis,...

S&P Global’s Board of Directors recently approved a 1.0% increase in its regular quarterly cash dividend, lifting the payout from US$0.96 to US$0.97 per share, payable on March 11, 2026 to shareholders of record on February 25, 2026, and raising the annualized dividend rate to US$3.88 per share. The modest dividend increase, which reflects the expected 2026 spin-off of S&P Global’s Mobility division, comes alongside reports highlighting the company’s long dividend-growth record and its...

While Bergman & Beving AB (publ) ( STO:BERG B ) might not have the largest market cap around , it received a lot of...

Telix Pharmaceuticals recently reported that China’s NMPA accepted the New Drug Application for its prostate cancer imaging agent TLX591-Px, while the first U.S. patient was dosed in the BiPASS Phase 3 trial assessing Illuccix and Gozellix in pre-biopsy diagnosis. Early data showing high positive predictive value in Chinese patients and a trial aimed at reducing unnecessary biopsies highlight how Telix’s PSMA-PET portfolio could influence prostate cancer care pathways across major...